Trial intelligence / Profile preview

Cancer-DACUS: LMWH Duration in Cancer Patients with DVT

NCT00450645Phase 4Unknown

Sponsor
Azienda Ospedaliera Universitaria Policlinico
Start
Mar 2005
Primary completion
Mar 2009
Countries
1
01

Overview

A Phase 4 trial of low molecular weight heparin calcium in deep vein thrombosis (DVT), venous thromboembolism (VTE), sponsored by Azienda Ospedaliera Universitaria Policlinico. Status: unknown.

02

Drugs

low molecular weight heparin calcium
03

Conditions

deep vein thrombosis (DVT)venous thromboembolism (VTE)

Beyond the preview

Go deeper on NCT00450645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00450645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call